Attached files
| file | filename |
|---|---|
| 10-K - SensiVida Medical Technologies, Inc. | v188425_10k.htm |
| EX-31.1 - SensiVida Medical Technologies, Inc. | v188425_ex31-1.htm |
| EX-31.2 - SensiVida Medical Technologies, Inc. | v188425_ex31-2.htm |
18
U.S.C. SECTION 1350,
AS
ADOPTED PURSUANT TO
SECTION 906
OF THE SARBANES-OXLEY ACT OF 2002
In
connection with the Annual Report on Form 10-K of SensiVida Medical
Technologies, Inc. (the "Company") for the year ended February 28, 2010, as
filed with the Securities and Exchange Commission on the date hereof (the
"Report"), Jose Mir, as President of the Company, and Frank D. Benick, as Chief
Financial Officer of the Company, each hereby certifies, pursuant to 18 U.S.C.
§1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002,
that:
(1) The Report fully complies with the
requirements of §13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2) The information contained
in the Report fairly presents, in all material respects, the financial condition
and results of operations of the Company.
|
By:
|
/s/Jose
Mir
|
|
|
Jose
Mir
|
||
|
Chief
Executive Officer
|
||
|
Date:
June 16, 2010
|
By:
|
/s/
Frank D. Benick
|
|
Frank
D. Benick
|
||
|
Chief
Financial
Officer
|
This
certification accompanies each Report pursuant to §906 of the Sarbanes-Oxley Act
of 2002 and shall not, except to the extent required by the Sarbanes-Oxley Act
of 2002, be deemed filed by the Company for purposes of §18 of the Securities
Exchange Act of 1934, as amended.
A signed
original of this written statement required by §906 has been provided to the
Company and will be retained by the Company and furnished to the Securities and
Exchange Commission or its staff upon request.